After 24 h of pre-adaption, the serum bottles were moved back into the anaerobic chamber where 4 ml of a freshly prepared 106 cells/mL C. jejuni culture resuspended in ADS was added to all bottles except the non-inoculated treatment (NI) for a final concentration of 105 CFU/mL. For specific treatments involving casein supplements, 0.1 g of the appropriate vitamin free-casein type (intact (Envigo®, Madison, WI, USA), enzyme hydrolyzed (MilliporeSigma, Burlington, MA, USA), or acid hydrolysate of casein (MilliporeSigma, Burlington, MA, USA) was added to the serum bottles. The study included five distinct treatments: non-inoculated (NI), inoculated with C. jejuni (IN), and three supplemented groups, intact casein (IC), enzyme hydrolysate (EH), acid hydrolysate (AH), that were all inoculated with C. jejuni. We opted not to include additional controls for supplemented groups without Campylobacter, instead using non-inoculated and inoculated treatments without casein supplementations for comparative analyses with the casein-enriched groups. Because Campylobacter naturally inhabits poultry cecal compartments [21 (link)], we confirmed the absence of culturable Campylobacter in the NI group and confirm the inocula, the 0-hour samples were plated on mCCDA [22 (link)]. At 0, 24, and 48 h post-inoculation, duplicate 1 mL samples were taken for microbiome sequencing and metabolomic analysis. The samples were flash-frozen in liquid nitrogen and stored at -80°C until processing. An overview of the procedure is described in
Cecal Microbiome and Metabolism Response to Campylobacter Exposure and Casein Supplementation
After 24 h of pre-adaption, the serum bottles were moved back into the anaerobic chamber where 4 ml of a freshly prepared 106 cells/mL C. jejuni culture resuspended in ADS was added to all bottles except the non-inoculated treatment (NI) for a final concentration of 105 CFU/mL. For specific treatments involving casein supplements, 0.1 g of the appropriate vitamin free-casein type (intact (Envigo®, Madison, WI, USA), enzyme hydrolyzed (MilliporeSigma, Burlington, MA, USA), or acid hydrolysate of casein (MilliporeSigma, Burlington, MA, USA) was added to the serum bottles. The study included five distinct treatments: non-inoculated (NI), inoculated with C. jejuni (IN), and three supplemented groups, intact casein (IC), enzyme hydrolysate (EH), acid hydrolysate (AH), that were all inoculated with C. jejuni. We opted not to include additional controls for supplemented groups without Campylobacter, instead using non-inoculated and inoculated treatments without casein supplementations for comparative analyses with the casein-enriched groups. Because Campylobacter naturally inhabits poultry cecal compartments [21 (link)], we confirmed the absence of culturable Campylobacter in the NI group and confirm the inocula, the 0-hour samples were plated on mCCDA [22 (link)]. At 0, 24, and 48 h post-inoculation, duplicate 1 mL samples were taken for microbiome sequencing and metabolomic analysis. The samples were flash-frozen in liquid nitrogen and stored at -80°C until processing. An overview of the procedure is described in
Corresponding Organization : University of Wyoming
Variable analysis
- Addition of casein supplements (intact, enzyme hydrolyzed, or acid hydrolysate of casein)
- Microbiome composition
- Metabolomic profile
- Pre-adaptation of cecal microbiota in a microaerobic atmosphere at 42°C for 24 hours
- Incubation of cultures in an anaerobic chamber at 42°C with continuous agitation
- Positive control: Inoculation with C. jejuni (IN group)
- Negative control: Non-inoculated (NI) group
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!